Literature DB >> 16254696

Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.

Wolfgang Brück1.   

Abstract

Multiple sclerosis is a disease of the central nervous system that destroys myelin, oligodendrocytes, neurons and axons. Historically considered to be caused by an autoimmune process mainly affecting myelin and oligodendrocytes in the white matter, recent data provide evidence that a generalized, diffuse neurodegenerative process plays an important role in the pathogenesis of MS. There is a high density of axonal transections in active demyelinating lesions, but also persistent low-level axonal damage in inactive plaques and diffuse axonal and neuronal loss throughout the nervous system. Initial axonal injury appears to be closely related to inflammation, but is not restricted to the lesions themselves. Damage may be propagated throughout the nervous system by anterograde Wallerian, retrograde or transynaptic degeneration. Cumulative tissue loss in the grey and white matter, especially of axons, is important and probably the principal determinant of accumulation of irreversible neurological disability and of conversion to a progressive disease course.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254696     DOI: 10.1007/s00415-005-5003-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Authors:  J W Peterson; L Bö; S Mörk; A Chang; B D Trapp
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

5.  Early onset of axonal degeneration in double (plp-/-mag-/-) and hypomyelinosis in triple (plp-/-mbp-/-mag-/-) mutant mice.

Authors:  T Uschkureit; O Sporkel; J Stracke; H Bussow; W Stoffel
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

6.  Formation of compact myelin is required for maturation of the axonal cytoskeleton.

Authors:  S T Brady; A S Witt; L L Kirkpatrick; S M de Waegh; C Readhead; P H Tu; V M Lee
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

7.  Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination.

Authors:  Corinna Lappe-Siefke; Sandra Goebbels; Michel Gravel; Eva Nicksch; John Lee; Peter E Braun; Ian R Griffiths; Klaus-Armin Nave
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

8.  Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

Authors:  Tanja Kuhlmann; Gueanelle Lingfeld; Andreas Bitsch; Jana Schuchardt; Wolfgang Brück
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

9.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

10.  Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

Authors:  Lars Bø; Christian A Vedeler; Harald I Nyland; Bruce D Trapp; Sverre J Mørk
Journal:  J Neuropathol Exp Neurol       Date:  2003-07       Impact factor: 3.685

View more
  22 in total

1.  Rostrocaudal analysis of corpus callosum demyelination and axon damage across disease stages refines diffusion tensor imaging correlations with pathological features.

Authors:  Mingqiang Xie; Jennifer E Tobin; Matthew D Budde; Chin-I Chen; Kathryn Trinkaus; Anne H Cross; Dennis P McDaniel; Sheng-Kwei Song; Regina C Armstrong
Journal:  J Neuropathol Exp Neurol       Date:  2010-07       Impact factor: 3.685

Review 2.  Autoimmune modulation of astrocyte-mediated homeostasis.

Authors:  Thomas Korn; Mahendra Rao; Tim Magnus
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

3.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

4.  Increased spontaneous apoptosis of rat primary neurospheres in vitro after experimental autoimmune encephalomyelitis.

Authors:  Mir Sajad; Jamil Zargan; Jyoti Sharma; Raman Chawla; Rajesh Arora; Sadiq Umar; Haider A Khan
Journal:  Neurochem Res       Date:  2011-03-30       Impact factor: 3.996

Review 5.  Neuroprotection in multiple sclerosis: a therapeutic approach.

Authors:  Amir-Hadi Maghzi; Alireza Minagar; Emmanuelle Waubant
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749

6.  Axonal damage in multiple sclerosis.

Authors:  Jeffery D Haines; Matilde Inglese; Patrizia Casaccia
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

7.  Magnetic resonance imaging of cells in experimental disease models.

Authors:  Naser Muja; Jeff W M Bulte
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-07       Impact factor: 9.795

Review 8.  Will the real multiple sclerosis please stand up?

Authors:  Peter K Stys; Gerald W Zamponi; Jan van Minnen; Jeroen J G Geurts
Journal:  Nat Rev Neurosci       Date:  2012-06-20       Impact factor: 34.870

9.  Upregulation of CSPG3 accompanies neuronal progenitor proliferation and migration in EAE.

Authors:  Mir Sajad; Jamil Zargan; Raman Chawla; Sadiq Umar; Haider A Khan
Journal:  J Mol Neurosci       Date:  2010-11-25       Impact factor: 3.444

10.  Endurance training in MS: short-term immune responses and their relation to cardiorespiratory fitness, health-related quality of life, and fatigue.

Authors:  J Bansi; W Bloch; U Gamper; S Riedel; J Kesselring
Journal:  J Neurol       Date:  2013-09-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.